FilingFirehose · free AI preview
Prelude Therapeutics Inc
PRLD · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Prelude Therapeutics Inc filed a material officer departure (8-K Item 5.02) on April 15, 2026, with no cyber incidents flagged in the past 90 days. While a single departure event does not indicate systematic distress, executive turnover can signal strategic shifts or operational challenges that warrant closer examination. The full $49 Report adds detailed 8-K context, a dilution risk score based on 12 months of financing activity, and AI-detected risk signals across the broader filing landscape.
Want the full 5-section $49 Report on PRLD?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.